Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

VN1R4 Activators

VN1R4 can engage various signaling pathways to ensure its activation. Sodium fluoride and forskolin are notable for their ability to directly stimulate adenylate cyclase, an enzyme that catalyzes the conversion of ATP to cAMP. The increase in intracellular cAMP levels is a well-established mechanism for activating cAMP-dependent pathways, which, in the context of VN1R4, translates to the protein's activation. Other chemicals, such as isoproterenol and adrenaline, operate through beta-adrenergic receptors to achieve a similar outcome. By binding to these receptors, they trigger a cascade of intracellular events that also culminate in adenylate cyclase activation and a subsequent rise in cAMP levels. This elevation in cAMP serves as a second messenger that can activate VN1R4 by propagating signaling through the cAMP-dependent route.

PGE2, histamine, dopamine, noradrenaline, and epinephrine also rely on receptor-mediated processes to increase cAMP. They each have specific receptors that, upon activation, engage Gs proteins to stimulate adenylate cyclase. This stimulation results in an amplified production of cAMP, which then acts to activate VN1R4. Another approach to increase cAMP levels and activate VN1R4 is through the inhibition of phosphodiesterases by IBMX, which prevents the degradation of cAMP, ensuring that it remains abundant within the cell to exert its effects. Glucagon operates through its own receptor to add to the pool of cAMP, further ensuring that VN1R4 activation is achieved. Cholera toxin, although different in its mode of action, causes continuous activation of adenylate cyclase due to ADP-ribosylation of the Gs alpha subunit, leading to prolonged increases in cAMP and sustained activation of VN1R4. The common thread amongst these chemicals is the elevation of cAMP levels, which serves as a central node in the activation of VN1R4.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sodium Fluoride

7681-49-4sc-24988A
sc-24988
sc-24988B
5 g
100 g
500 g
$40.00
$46.00
$100.00
26
(4)

Sodium fluoride activates adenylate cyclase, leading to an increase in cAMP levels, which could activate VN1R4 by enhancing the cAMP-dependent pathway.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Isoproterenol is a beta-adrenergic agonist that stimulates adenylate cyclase activity, thereby increasing cAMP levels, which in turn might activate VN1R4 within the cAMP signaling pathway.

PGE2

363-24-6sc-201225
sc-201225C
sc-201225A
sc-201225B
1 mg
5 mg
10 mg
50 mg
$57.00
$159.00
$275.00
$678.00
37
(1)

Prostaglandin E2 (PGE2) binds to its G-protein coupled receptors, leading to an increase in cAMP production. This increase in cAMP can activate VN1R4 through the cAMP signaling cascade.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX is a non-specific inhibitor of phosphodiesterases, enzymes that degrade cAMP. By inhibiting these enzymes, IBMX raises cAMP levels, which may lead to the activation of VN1R4.

Histamine, free base

51-45-6sc-204000
sc-204000A
sc-204000B
1 g
5 g
25 g
$94.00
$283.00
$988.00
7
(1)

Histamine can bind to H2 receptors that are coupled with Gs proteins. Activation of these receptors can lead to an increase in cAMP, which may activate VN1R4 through the cAMP signaling pathway.

Dopamine

51-61-6sc-507336
1 g
$290.00
(0)

Dopamine can activate dopamine D1 receptors which are coupled to Gs proteins, leading to increased cAMP levels and potential activation of VN1R4 through cAMP-mediated pathways.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Adrenaline interacts with beta-adrenergic receptors, which can lead to increased production of cAMP and subsequent activation of VN1R4 through the cAMP signaling pathway.

L-Noradrenaline

51-41-2sc-357366
sc-357366A
1 g
5 g
$326.00
$485.00
3
(0)

Noradrenaline binds to beta-adrenergic receptors, increasing cAMP levels and potentially activating VN1R4 through the cAMP-dependent signaling pathways.